Processa Pharmaceuticals, Inc. (PCSA)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 13, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Processa Pharmaceuticals, Inc.'s Preliminary Proxy Statement filed on July 31, 2025. They remind the company that it is ultimately responsible … | Read Filing EDGAR |
| Aug. 8, 2025 | CORRESP | Neutral/Informational | Low | Processa Pharmaceuticals, Inc. submitted a correspondence to the SEC in response to comments regarding their preliminary proxy statement filed on July 31, 2025. The SEC requested … | Read Filing EDGAR |
| Aug. 6, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Processa Pharmaceuticals, Inc.'s Preliminary Proxy Statement on Schedule 14A filed on July 31, 2025, and has issued a comment regarding the need for additiona… | Read Filing EDGAR |
| Jun. 13, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from H.C. Wainwright & Co., LLC to the SEC pertains to Processa Pharmaceuticals, Inc.'s request for the acceleration of the effective date of their registration… | Read Filing EDGAR |
| Jun. 13, 2025 | CORRESP | Neutral/Informational | High | Processa Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement on Form S-1. The company is seeking to ha… | Read Filing EDGAR |
| May. 7, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated May 7, 2025, informs Processa Pharmaceuticals, Inc. that they do not intend to review the company's Draft Registration Statement on Form S-1 submitted… | Read Filing EDGAR |